Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: Possible role of the noradrenergic nervous system

被引:61
|
作者
Szot, Patricia [1 ,2 ]
机构
[1] Vet Adm Puget Sound Hlth Care Syst, NW Network Mental Illness Res Educ & Clin Ctr, Seattle, WA USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
关键词
Alzheimer's disease; Parkinson's disease; Temporal lobe epilepsy; Locus coeruleus; Noradrenergic; Hippocampus; LOCUS-COERULEUS NEURONS; SUBSTANTIA-NIGRA; EFFERENT PROJECTIONS; DEPRESSION; DEMENTIA; CERULEUS; NOREPINEPHRINE; PATHOPHYSIOLOGY; SUBPOPULATIONS; SUSCEPTIBILITY;
D O I
10.1111/j.1528-1167.2012.03476.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The neurodegenerative disorders Alzheimers disease (AD) and Parkinsons disease (PD) share in common the neuropathologic loss of locus coeruleus (LC) noradrenergic neurons. In addition, these two neurodegenerative disorders share two symptoms that define these disorders: cognitive impairment and depression. The hippocampus is a region that is known to play a role in cognition and depression, and the hippocampus receives sole noradrenergic innervation from LC neurons. However, it is unclear how the loss of LC noradrenergic neurons contributes to these common symptoms in these two disorders. Epilepsy is not considered a neurodegenerative disorder, but the hippocampus is severely affected in temporal lobe epilepsy. Of interest, cognitive impairment and depression are also common comorbid disorders in temporal lobe epilepsy. This article describes common symptoms among these three neurologic disorders and a possible role of the noradrenergic nervous system.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 50 条
  • [1] Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease
    McMillan, Pamela J.
    White, Sylvia S.
    Franklin, Allyn
    Greenup, J. Lynne
    Leverenz, James B.
    Raskind, Murray A.
    Szot, Patricia
    BRAIN RESEARCH, 2011, 1373 : 240 - 252
  • [2] The Noradrenergic System in Parkinson's Disease
    Paredes-Rodriguez, Elena
    Vegas-Suarez, Sergio
    Morera-Herreras, Teresa
    De Deurwaerdere, Philippe
    Miguelez, Cristina
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [3] Parkinson's disease and noradrenergic system
    Brefel-Courbon, C
    PRESSE MEDICALE, 2002, 31 (26): : 1240 - 1242
  • [4] The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease
    Maiese, Kenneth
    CURRENT NEUROVASCULAR RESEARCH, 2023, 20 (03) : 314 - 333
  • [5] The possible role of the immune system in Alzheimer's disease
    Marx, F
    Blasko, I
    Pavelka, M
    Grubeck-Loebenstein, B
    EXPERIMENTAL GERONTOLOGY, 1998, 33 (7-8) : 871 - 881
  • [6] The Role of Glymphatic System in Alzheimer's and Parkinson's Disease Pathogenesis
    Buccellato, Francesca R.
    D'Anca, Marianna
    Serpente, Maria
    Arighi, Andrea
    Galimberti, Daniela
    BIOMEDICINES, 2022, 10 (09)
  • [7] The role of the dopaminergic system in apathy in Parkinson's disease and Alzheimer's disease: An experimental approach
    Aalten, Pauline
    Drijgers, R.
    Leentjens, A.
    Verhey, F.
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 : S144 - S145
  • [8] Role of epigenetics in Alzheimer's and Parkinson's disease
    Kwok, John B. J.
    EPIGENOMICS, 2010, 2 (05) : 671 - 682
  • [9] Possible role of the olfactory system in Alzheimer's disease genesis
    Bobkova, NV
    Nesterova, IV
    Medvinskaya, NI
    Aleksandrova, IY
    Samokhin, AN
    Gershovich, JG
    Gershovich, PM
    Yashin, VA
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2005, 2005, : 91 - 95
  • [10] Detrimental and synergistic role of epilepsy——Alzheimer's disease risk factors
    Mikhail A.Filippov
    vasily v.vorobyov
    Neural Regeneration Research, 2019, (08) : 1376 - 1377